T
48
3
NOC
40
-10
QCOM
55
-2
NTAP
61
-3
GS
75
-4
ALLE
41
-7
MRO
46
3
RSG
77
4
PFG
50
-2
SLB
56
-3
EXPE
96
-3
BMY
61
-3
TXN
49
-6
SCHW
65
-2
EW
32
3
BLK
70
-2
KSS
42
-3
HCP
70
-4
HPE
70
2
R
77
2
T
48
3
NOC
40
-10
QCOM
55
-2
NTAP
61
-3
GS
75
-4
ALLE
41
-7
MRO
46
3
RSG
77
4
PFG
50
-2
SLB
56
-3
EXPE
96
-3
BMY
61
-3
TXN
49
-6
SCHW
65
-2
EW
32
3
BLK
70
-2
KSS
42
-3
HCP
70
-4
HPE
70
2
R
77
2
Financhill
Back

Evaxion Biotech AS 10K Form

Sell
1

EVAX
Evaxion Biotech AS

Last Price:
1.84
Seasonality Move:
-49.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EVAX News And Ratings

See the #1 stock for the next 7 days that we like better than EVAX

EVAX Financial Statistics

Sales & Book Value

Annual Sales: $73K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.01
Price / Book: 179.4

Profitability

EPS (TTM): -2.80000
Net Income (TTM): $-11.46M
Gross Margin: --
Return on Equity: 0%
Return on Assets: -69.51%

Evaxion Biotech AS Earnings Forecast

Key Evaxion Biotech AS Financial Ratios

  • The Research & Development expenses have been 16,323.29% of Revenue.
  • The Interest Expense is -4.05% of Operating Income.
  • The Net Earning history of EVAX is -30,308.22% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Evaxion Biotech AS Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EVAX
Website: evaxion-biotech.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EVAX Technical Analysis vs Fundamental Analysis

Sell
1
Evaxion Biotech AS (EVAX) is a Sell

Is Evaxion Biotech AS a Buy or a Sell?